Increased expression of HMGB3: a novel independent prognostic marker of worse outcome in patients with esophageal squamous cell carcinoma.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Clinical and Experimental Pathology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 25755721PMCID PMC4348853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic value of HMGB3 expression in patients with non-small cell lung cancer

  2013cited by this paper
• Prognostic relevance and therapeutic implications of centromere protein F expression in patients with esophageal squamous cell carcinoma.

  2013cited by this paper
• HMGB3 characterization in gastric cancer.

  2013cited by this paper
• Tumor Suppressive Function of mir-205 in Breast Cancer Is Linked to HMGB3 Regulation

  2013cited by this paper
• The Expression of High Mobility Group Box 1 is Associated with Lymph Node Metastasis and Poor Prognosis in Esophageal Squamous Cell Carcinoma

  2012cited by this paper
• The HMGB protein gene family in zebrafish: Evolution and embryonic expression patterns.

  2011cited by this paper
• High-mobility group box 1 and cancer.

  2010cited by this paper
• HMGB proteins: interactions with DNA and chromatin.

  2010cited by this paper
• Sumoylation controls retinal progenitor proliferation by repressing cell cycle exit in Xenopus laevis.

  2010cited by this paper
• The expression of HMGB1 protein and its receptor RAGE in human malignant tumors

  2010cited by this paper
• Tissue-Specific Expression Profiling of Receptor for Advanced Glycation End Products and Its Soluble Forms in Esophageal and Lung Cancer

  2010cited by this paper
• Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells.

  2009cited by this paper
• Nucleosome regulator Xhmgb3 is required for cell proliferation of the eye and brain as a downstream target of Xenopus rax/Rx1.

  2006cited by this paper
• Hmgb3 regulates the balance between hematopoietic stem cell self-renewal and differentiation

  2006cited by this paper
• p53 mutation profile of squamous cell carcinomas of the esophagus in Kashmir (India): A high‐incidence area

  2005cited by this paper
• HMGB proteins and gene expression.

  2003cited by this paper
• Intracellular high mobility group B1 protein (HMGB1) represses HIV-1 LTR-directed transcription in a promoter- and cell-specific manner.

  2003cited by this paper
• Familial aggregation of oesophageal cancer in a high incidence area in China.

  1997cited by this paper
• Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.

  1997cited by this paper
• Familial aggregation of oesophageal cancer in Yangcheng County, Shanxi Province, China.

  1992cited by this paper
• Epidemiology of esophageal cancer in China.

  1982cited by this paper

• Dualistic Roles of High Mobility Group Box 1 in Cancer and Inflammation

  2025cites this paper
• TGIF2-mediated HMGB3 overexpression promotes esophageal squamous cell carcinoma proliferation and metastasis through TLR3/TGF-β signaling.

  2025cites this paper
• HOXA11-As Promotes Lymph Node Metastasis Through Regulation of IFNL and HMGB Family Genes in Pancreatic Cancer

  2024cites this paper
• Critical role of exosome, exosomal non-coding RNAs and non-coding RNAs in head and neck cancer angiogenesis.

  2024cites this paper
• Structure and Functions of HMGB3 Protein

  2024cites this paper
• The research progress on radiation resistance of cervical cancer

  2024cites this paper
• Involvement of HIF1α/Reg protein in the regulation of HMGB3 in myocardial infarction.

  2023cites this paper
• CBDCEM: An effective centrality based differential co-expression method for critical gene finding

  2022cites this paper
• Identification of Potential Biomarkers Using Integrative Approach: A Case Study of ESCC

  2022cites this paper
• Overexpression of HMGB3 and its prognostic value in breast cancer

  2022cites this paper
• A novel lnc-LAMC2-1:1 SNP promotes colon adenocarcinoma progression by targeting miR-216a-3p/HMGB3

  2022cites this paper
• Expression, tumor immune infiltration, and prognostic impact of HMGs in gastric cancer

  2022cites this paper
• HMGB3 Targeted by miR-145-5p Impacts Proliferation, Migration, Invasion, and Apoptosis of Breast Cancer Cells

  2022cites this paper
• HMGB3 inhibition by miR-142-3p/sh-RNA modulates autophagy and induces apoptosis via ROS accumulation and mitochondrial dysfunction and reduces the tumorigenic potential of human breast cancer cells.

  2022cites this paper
• MicroRNA-429 acts as a tumor suppressor in colorectal cancer by targeting high mobility group box 3

  2021cites this paper
• miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells.

  2021cites this paper
• LINC00857 promotes colorectal cancer progression by sponging miR-150-5p and upregulating HMGB3 (high mobility group box 3) expression

  2021cites this paper
• Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis

  2021cites this paper
• TGIF2-Induced HMGB3 Promotes Esophageal Squamous Cell Carcinoma Progression Through TGFβ Signaling

  2021cites this paper
• Nuclear exosome HMGB3 secreted by nasopharyngeal carcinoma cells promotes tumour metastasis by inducing angiogenesis

  2021cites this paper
• Integrated analysis of ceRNA network and tumor-infiltrating immune cells in esophageal cancer

  2021cites this paper
• Expression and clinical significance of B cell translocation gene 2 in esophageal squamous cell carcinoma.

  2021cites this paper
• Demethylated miR-216a Regulates High Mobility Group Box 3 Promoting Growth of Esophageal Cancer Cells Through Wnt/β-Catenin Pathway

  2021cites this paper
• Involvement of Long Non-Coding RNAs in Glucose Metabolism in Cancer

  2021cites this paper
• The role of high mobility group protein B3 (HMGB3) in tumor proliferation and drug resistance

  2021cites this paper
• Targeting Chromosomal Architectural HMGB Proteins Could Be the Next Frontier in Cancer Therapy

  2020cites this paper
• The pathogenicity, structural and functional exploration of human HMGB1 single nucleotide polymorphisms using in silico study

  2020cites this paper
• LncRNA SNHG5 promotes nasopharyngeal carcinoma progression by regulating miR-1179/HMGB3 axis

  2020cites this paper
• A Genetic Screen for Human Genes Suppressing FUS Induced Toxicity in Yeast

  2020cites this paper
• Proteomics-based Predictive Model for the Early Detection of Metastasis and Recurrence in Head and Neck Cancer

  2020cites this paper
• High mobility group box 3 promotes cervical cancer proliferation by regulating Wnt/β-catenin pathway

  2020cites this paper
• Targeting HMGB3/hTERT axis for radioresistance in cervical cancer

  2020cites this paper
• Effects of microRNA‐513b on cell proliferation, apoptosis, invasion, and migration by targeting HMGB3 through regulation of mTOR signaling pathway in non‐small‐cell lung cancer

  2019cites this paper
• CMAR_A_204357 5075..5089

  2019cites this paper
• Downregulation of microRNA-532-5p promotes the proliferation and invasion of bladder cancer cells through promotion of HMGB3/Wnt/β-catenin signaling.

  2019cites this paper
• Down-regulated expressed protein HMGB3 inhibits proliferation and migration, promotes apoptosis in the placentas of fetal growth restriction.

  2019cites this paper
• Integrated analysis of 10 lymphoma datasets identifies E2F8 as a key regulator in Burkitt's lymphoma and mantle cell lymphoma.

  2019cites this paper
• MicroRNA-758 inhibits cervical cancer cell proliferation and metastasis by targeting HMGB3 through the WNT/β-catenin signaling pathway.

  2019cites this paper
• HMGB3 silence inhibits breast cancer cell proliferation and tumor growth by interacting with hypoxia-inducible factor 1α

  2019cites this paper
• Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer.

  2019cites this paper
• Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer

  2019cites this paper
• Knockdown of high mobility group box 3 impairs cell viability and colony formation but increases apoptosis in A549 human non-small cell lung cancer cells.

  2019cites this paper
• Role of microRNAs in the resistance of colorectal cancer to chemoradiotherapy.

  2018cites this paper
• A novel scoring model for predicting mortality risk in patients with cirrhosis and hepatorenal syndrome

  2018cites this paper
• Proteogenomic view of cancer epigenetics: the impact of DNA methylation on the cancer proteome

  2018cites this paper
• Association and interaction between model for end-stage liver disease score and minimally invasive treatment with regard to mortality of patients with hepatitis B virus-associated hepatocellular carcinoma and portal vein tumor thrombi.

  2018cites this paper
• High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma

  2018cites this paper
• Overexpression of miR-758 inhibited proliferation, migration, invasion, and promoted apoptosis of non-small cell lung cancer cells by negatively regulating HMGB

  2018cites this paper
• Upregulation of miR-200b Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Targeting HMGB3 Protein

  2018cites this paper
• HMGB3 promotes the proliferation and metastasis of glioblastoma and is negatively regulated by miR‐200b‐3p and miR‐200c‐3p

  2018cites this paper
• Abnormal expression of HMGB-3 is significantly associated with malignant transformation of hepatocytes

  2018cites this paper
• Potential new biomarkers for squamous carcinoma of the uterine cervix

  2018cites this paper
• A genetic approach to evaluation of short stature of undetermined cause.

  2018cites this paper
• Predictive value of serum gamma-glutamyltransferase levels in patients with hepatocellular carcinoma.

  2017influential citation
• HMGB3 promotes growth and migration in colorectal cancer by regulating WNT/β-catenin pathway

  2017cites this paper
• HMGB3 modulates ROS production via activating TLR cascade in Apostichopus japonicus.

  2017cites this paper
• Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.

  2016cites this paper
• The Tumor Suppressive Role of MiRNA-509-5p by Targeting FOXM1 in Non-Small Cell Lung Cancer

  2016cites this paper
• Knockdown of High Mobility Group-Box 3 (HMGB3) Expression Inhibits Proliferation, Reduces Migration, and Affects Chemosensitivity in Gastric Cancer Cells

  2016cites this paper
• Defining the mechanistic role of high mobility group box-1 and its utility as a biomarker in the inflammatory pathogenesis of epilepsy

  2015cites this paper
• Prognostic markers in esophageal cancer: from basic research to clinical use

  2015cites this paper
• tumor suppressor in colorectal cancer by targeting high mobility group box 3

  year unknowncites this paper